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Abstract  
Background: The small molecule pifithrin-µ reversibility inhibits the mitochondrial pathway 
of apoptosis. The neuronal effects of pifithrin-µ applied after cardiac arrest are unknown. We 
hypothesized that pifithrin-µ reduces neuronal damage in the most vulnerable brain region, 
the hippocampus, after cardiac arrest.   
Methods: In two randomized controlled series we administered pifithrin-µ or control in 109 
rats resuscitated after 8 or 10 minutes of cardiac arrest. Neuronal damage was blindly 
assessed with histology (Fluoro Jade B: FJB, cresyl violet: CV) in the most vulnerable brain 
region (CA1 segment of hippocampus) and with a series of neurobehavioral tests (Open Field 
Task, Tape-Removal Test, Morris Water Maze test). Mixed ANOVA was used to combine 
both series, simple comparisons were done with t-tests or Mann–Whitney U test. 
Results: Pifithrin-µ reduced the number of degenerating, FJB-positive neurons by 25% 
(mixed ANOVA p group = 0.014). This was more prominent after 8 minutes cardiac arrest (8 
minutes arrest pifithrin-µ 94 ± 47 vs control 128 ± 37; n=11 each; 10 minutes arrest pifithrin-
µ 78 ± 44, n=15 vs control 101 ± 31, n=18; p group* arrest length interaction = 0.622). The 
reduction of ischemic CV-positive neurons in pifithrin-µ animals was not significant 
(ANOVA p group = 0.063). No significant group differences were found in neurobehavioral 
testing. 
Conclusion: Temporarily inhibition of apoptosis with pifithrin-µ after cardiac arrest decreases 
the number of injured neurons in the CA1 segment of hippocampus in a cardiac arrest rat 
model, without clinical correlate. Further studies should elucidate the role of this 
neuroprotective agent in different settings and with longer cardiac arrest. 
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Introduction 
Cardiac arrest affects more than 300 000 persons annually alone in the United States (1, 2) 
and is the most important cause of global cerebral ischemia. Only a minority of resuscitated 
patients is discharged in good neurological condition (3, 4). Global cerebral ischemia does 
not necessarily lead to immediate neuronal death, but initiates the apoptotic cascade, which 
results in neurodegeneration (5). This late neuronal degeneration may open a window of 
opportunity to mitigate the devastating effects of ischemia on the brain. 
Delayed cell death and apoptosis following stress is directed by the tumor-suppressor gene-
product p53 (6, 7). Transgenic mice with definitive suppression of p53 ultimately develop 
cancer, but suppression of p53 might have short term advantages. Some studies have found 
promising effects, e.g. mice with reduced p53 activity survive otherwise lethal irradiation (8). 
Inhibition of p53 restores spontaneous locomotion of the animals after experimental stroke 
(9), protects neonatal rat brain from hypoxic-ischemic injury (10) and attenuate autophagic 
and apoptotic cell death in the cortex and hippocampus when given before cardiac arrest in 
rats (11). 
The effect of blocking the p53 pathway after global ischemic-reperfusion injury induced by 
cardiac arrest is unknown. We assessed the feasibility and effect of a single dose of the anti-
apoptotic small molecule pifithrin-µ given after cardiac arrest of either 8 or 10 minutes. We 
hypothesized that pifithrin-µ reduces the numbers of degenerated cells in the most vulnerable 
part of the brain, the hippocampus Cornu Ammonis 1 (CA-1) segment, and improves 
outcome measured with neurobehavioral testing. 
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Material and Methods 
The study included two series:  1. randomized open label allocation of pifithrin (PIF) or 
placebo (C) following return of spontaneous circulation (ROSC) after 8 minutes of cardiac 
arrest (n=74) and evaluation of brain histology by a blinded assessor and neurobehavioral 
testing on day 1 (n=23) or 5 (n= 22) or neurobehavioral testing with a Moris Water Maze 
starting at day 10-14 (n=23) . Additional 6 rats were used as controls for brain histology 
(figure 1). 2. Randomized blinded allocation of PIF or C following ROSC after 10 minutes of 
cardiac arrest (n=40), and brain histology and neurobehavioral testing on day 5 (figure 
2a).The rational for the stepwise approach was to limit the number of used animals and to 
implement possible variations of the protocol (e.g. duration of cardiac arrest). 
All animal studies were approved by the Animal Care and Experimentation Committee of the 
Canton of Bern, Switzerland (BE 55/13 and BE 16/15) and followed the Swiss national 
guidelines for the performance of animal experiments. Adult male Wistar rats (9-10 weeks 
old, Janvier Labs, Le Genest-Saint-Isle, France)  were housed at the central animal facilities 
of the University of Bern with a 12/12h light/dark cycle at 22°C and food and water ad 
libitum.  
Randomization was done using concealed lots (sealed envelopes), in series 1. before 
anesthesia and in series 2. after return of spontaneous circulation. In case of failure of ROSC 
in series 1., the experiment was repeated immediately. Anesthesia, instrumentation, cardiac 
arrest/resuscitation, and postoperative care were standardized (12) and summarized in the 
Supplemental Digital Content, http://links.lww.com/SHK/A595. Briefly, after anesthesia 
induction, an endotracheal tube and arterial  and venous catheters were inserted. Temperature 
was managed using an adjustable temperature plate for cooling/heating, and an infrared bulb. 
Cardiac arrest was induced with iv-injection of potassium and esmolol (0.125 mmol 
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potassium and 9.375 mg esmolol per animal (corresponding to 0.363 mmol/kg body weight 
potassium and 27.3 mg/kg body weight esmolol). Resuscitation was performed  8 minutes 
(series 1.) or 10 minutes (series 2.) later with ventilation with 100% oxygen , cardiac massage 
by 2 fingers at a metronome-guided frequency of 220-min, and administration of epinephrine 
and calcium. 5 minutes after ROSC, the study medication in series 1. was given 
intraperitoneally [pifithrin-µ (Selleck Chemicals, via LuBioScience, Lucerne, Switzerland, 
substance for non-human use only)  dissolved in 4% dimethylsulfoxide (DMSO) in phosphate 
buffered saline (vehicle) to a final concentration of 0.8 g/l; dose 8 mg pifithrin-µ per kg]. In 
series 2.,  a precision syringe driver infused the study medication or matching vehicle at a rate 
of 1 ml/h for 4 hours [pifithrin-µ dissolved in 96% ethanol (10 mg/ml, vehicle) and after 
randomization further diluted in Ringer’s solution (12 mg pifithrin-µ per kg containing 1.2 ml 
ethanol 96% diluted to 4 ml]. The animals were euthanized according to the group allocation 
at day 1, 5 or after day 10 -14 with 150 mg/kg pentobarbital intraperitoneally. For brain 
histology, 150 ml iced normal saline was infused transcardially via the left ventricle before 
brain removal. The brain was post-fixed in buffered formalin (4% in phosphate buffered 
saline (PBS)) for 24 hours at 4°C and then transferred to a 18% sucrose solution in PBS at 
4°C until further processing. 
Cryo-sections were obtained by cutting the brain in 10 and 45 µm thick coronal sections 
using a Leica CM 1850 cryostat, after snap freezing of the tissue in methylbutane pre-cooled 
at -80 °C.  
Fluoro-Jade B (FJB) staining was performed to assess the extent of neuronal damage on 
representative slides of the CA1 segment, the only structure with consistent damage after 
resuscitation from cardiac arrest (13). Fluorescence pictures of the hippocampus were 
recorded with a Zeiss fluorescence microscope (Axiolmager M4, Zeiss, Germany) equipped 
with a digital camera (Axiocam HRC) at a 100-fold magnification with mosaic reconstruction 
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of individual captures using AxioVision software. The software Image J (Rasband, W.S., 
ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
http://imagej.nih.gov/ij/, 1997-2011) was used to determine the length (in mm) of the CA1 
structure under investigation and to count all FJB + cells in this structure. Fluoro-Jade results 
were therefore expressed by normalizing the total amount of positive cells by the length of 
the investigated CA1. 
The slices were also stained for Nissl substance with cresyl violet (CV). The percentage of 
cells with signs of ischemic damage  (shrunken appearance and condensed nucleus) was 
estimated in the CA1 region by visual observation under a bright-field microscope of three 
slides representing the dorsal (septal) part of the hippocampus. 
The histopathology was assessed in both series by the same expert (DG), who was blinded to 
the treatment and clinical data. In series 1. only the histopathologic examiner was blinded, 
whereas in series 2. the whole research team was blinded to treatment allocation.   
We assessed general health (including death) daily until the end of the experiment, and 
weight and neurological function daily from baseline (pre-arrest) until day 5 with an 
established wide-ranging neuroscore (NDS) (14). Further neurobehavioral tests performed 
was an Open Field Task (15), the Tape-Removal Test (16) in the series 1. and a standard 
Morris Water Maze test (17) performed after wound healing (starting day 10 to day 14) in the 
series 1. Details of the tests are described in the ESM.  
The data was tested for normality with the Shapiro-Wilk-Test, normal data were presented as 
mean ± SD, non-normal as medians and interquartile ranges [IQR]. Repeated assessments 
were compared in each experiment separately with a mixed ANOVA in normally distributed 
data with post-hoc tests corrected with Bonferroni’s method. Non-normal data distribution 
precluded ANOVA, so we compared baseline measurements with the Mann–Whitney U test 
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and the development within each group with the Friedman’s test. All non-parametric tests are 
indicated in Italics. Simple comparisons were performed using parametric (t-test) or non-
parametric statistics (Mann–Whitney U test) accordingly. Kaplan-Meier Survival Analysis 
(Log-Rank Test) was performed on series 2. only since there was only one animal which died 
after ROSC and treatment in the first series. 
Results of pathologic-anatomic examinations of both series were combined with a 2-way 
ANOVA (factor 1: group [pifithrin or control], factor 2: experiment [nr 1: 8 min cardiac 
arrest  or 2: 10 min cardiac arrest]).  This 2-way ANOVA was done once with the absolute 
cell count (numbers of damaged neurons), and once where the cell count of the damaged 
neurons in the PIF group was normalized to the respective cell count of the C group (x100%). 
A p < 0.05 was considered as significant. Calculations were performed using 
SigmaPlot/SigmaStat 12.3 (Systat Software GmbH, Erkrath, Germany). 
 
Results 
In experiment 1., 69 of the 74 randomized animals could be successfully resuscitated (93%). 
One rat from the pifithrin group died on day 2 (details see figure 1). In experiment 2, 40 of 
the 42 animals could be resuscitated (95%). Six animals died within one day (group PIF  n=2; 
group C n=4) and one control animal was euthanatized on day 3 because of failure to thrive 
and weight loss (Group PIF vs C Kaplan-Meier Survival Analysis (Log Rank Test) p=0.22). 
Altogether, 51 rats treated with pifithrin-µ and 50 control animals could be analyzed. 
Baseline characteristics of all animals in terms of temperature, hemodynamic and respiratory 
parameters as well as glucose and lactate variables did not differ between groups (see 
Supplemental Digital Content tables suppl 1a + 1b and suppl 2, 
http://links.lww.com/SHK/A595). Time from start of resuscitation to ROSC did not 
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significantly differ between the groups (8 min cardiac arrest: PIF 86 sec [73 – 100], C 76 sec 
[71 – 95], p = 0.40; 10 min cardiac arrest: PIF 55 sec [46 – 64], C 59 sec [45 – 65], p = 0.61). 
Doses of adrenaline and calcium did not differ between groups (details see Supplemental 
Digital Content tables suppl  3, http://links.lww.com/SHK/A595), but adrenaline dose was 
significantly lower in the Series 2 because of the shorter time to ROSC. 
There were no differences between groups in the trends of temperature, parameters of the 
aBGA (pH, pO2, pCO2), lactate and glucose (details see Supplemental Digital Content tables 
suppl  1a + 1b and suppl. 2, http://links.lww.com/SHK/A595), even though the animals 
developed a significant lactic acidosis after cardiac arrest with consecutive changes in pH. 
The same is true for hemodynamic parameters, where only changes over time were noted, but 
no differences between groups.  
Pathologic-anatomic examination with FJB staining at day 5 showed a reduction of damaged 
neurons in both series 1. (8 min cardiac arrest, PIF: 94 ± 46.9 vs C: 128 ± 36.6, p=0.084) and 
series 2. (10 min cardiac arrest, PIF: 78 ± 43.7 vs C: 101 ± 31.0, p=0.095). These results 
demonstrated a robust and significant reduction of neuronal damage by 25%, (2-way 
ANOVA of absolute cell count, group: p=0.014, experiment: p= 0.064, no interaction; 2-way 
ANOVA of cell count normalized to 100%, group: p=0.019, experiment: p= 0.850, no 
interaction), see table 1 and figure 3. In the CV staining, results followed the same trend, but 
did not reach significance, see table 2. 
In series 1., the histologic examinations performed on animals at Day 1 demonstrated only 
very few damaged neurons, the numbers were too low to perform statistics on them (see 
Supplemental Digital Content  table suppl. 4, http://links.lww.com/SHK/A595). The sectional 
CA1 area decreased between Day 1 and Day 5 in all animals (PIF p=0.011, C p<0.001), with 
significant reduced shrinking of the CA1 cell layer as an indirect marker of reduced neuronal 
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damage in the Pifithrin-µ group (mixed ANOVA, p group: 0.425, p time: <0.001, p for 
interaction: <0.001, details see table suppl. 5, http://links.lww.com/SHK/A595). The 3 non-
ischemic sham animals, euthanatized at day 5, did not depict any signs of neuronal damage 
(table suppl. 6, http://links.lww.com/SHK/A595). 
On the part of the general health and other neurobehavioral tests, no significant differences 
were observed in weight evolution, where all animals regained and surpassed their baseline 
weight. The Neuro Deficit Score was not sensitive enough to detect a difference compared to 
baseline beyond Day 2 in both groups. In the Tape Removal Test both groups returned to 
baseline levels after 5 days. In the open field the pifithrin-treated rats tended to be more 
mobile and to move longer distances, but without a significant difference (details see table 
suppl 7 a+b, http://links.lww.com/SHK/A595). The Morris Water Maze Tests (table supple 
7a, http://links.lww.com/SHK/A595) demonstrates a better learning capacity in the mean 
proximity to virtual platform (p group: 0.436, p time: <0.001, p group x time: 0.016), the 
other parameters (time to first crossing and time in platform quadrant) are not significantly 
different.  
 
Discussion 
The main finding of our study is that after cardiac arrest temporary inhibition of the p53 
mediated mitochondrial pathway of apoptosis with pifithrin-µ decreases neuronal damage in 
the most vulnerable structure of the brain, the hippocampus CA1 segment, by 25% . 
The p53 protein and its products have a central role in apoptosis (18). In unstressed cells, p53 
remains at low cytoplasmatic concentrations. Following different stressors, p53 is 
upregulated and exerts pro-apoptotic activity via transcription of Bcl-2-family proteins in the 
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nucleus (19), and through a mitochondrial pathway (6, 20). Dysfunctional p53 can be found 
in a wide range of cancer cells (21), but p53 is also involved in delayed cell death after 
traumatic brain injury (22), stroke (20), and contributes to side effects of anti-cancer drugs 
and irradiation. Inhibition of p53 by either drugs or gene knockout leads to improved survival 
after irradiation (8, 23), anti-cancer treatment (10, 24), neuronal ischemia (9, 10, 20, 25), 
myocardial ischemia (26) and oxidative stress in hepatoma cell lines (27). The small 
molecule pifithrin-α inhibits the transcription-dependent p53, whereas pifithrin-μ suppresses 
the p53 binding to the mitochondrial membrane (27). Targeting the mitochondrial pathway of 
p53 with pifithrin-μ compared to inhibition of transcription with pifithrin-α increases 
neuronal protection (10). In this experiment, Nijboer and colleagues demonstrated efficacy of 
pifithrin-µ in a neonatal unilateral ischemia and hypoxia rat model (10) with small group 
sizes (n<10). In their experiment , inhibition of apoptosis was accounted for the effect. 
Recently Ciu and colleagues confirmed the apoptotic (and autophagic) pathways and their 
subsequent inhibition with pifithrin-α in a asphyxial cardiac arrest model (11). In these 
experiments the rats were given pifithrin intracisternally before cardiac arrest, a model which 
differs in many aspects from ours. In our experiment we cannot prove the reduction of 
neuronal injury is caused by less apoptosis since we have not used a specific apoptosis 
staining (e.g. caspase 3 or TUNEL). Given the absence of injury on day one, and in similar 
experiments on day 2 (28), we assume that the observed degeneration on day 5 is due to the 
activation of the intrinsic apoptotic pathway.  
Damage of the dorso-septal pole of the hippocampus in rats results in impaired spatial 
learning and memory. Unfortunately we could not detect group differences in the 
neurobehavioral tests. Our functional tests revealed important, albeit not sustained, functional 
impairment after cardiac arrest. E.g. the time to remove the tapes in the Tape Removal Test 
returned to baseline at Day 5 in both groups (see Supplemental Digital Content, table suppl. 
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7a, http://links.lww.com/SHK/A595), so a difference cannot be obtained. Furthermore, the 
wide confidence intervals preclude characterizing a treatment effect. Variability is usually 
high in neuropsychological testing. We argue the tests are not sensitive enough to find a 
difference in these only mildly injured animals, and that our group sizes might have been too 
small for purposeful tests. For the tests of global activity and sensorimotor integration, which 
are often used and even have been developed for assessment in the setting of cardiac arrest 
(16), we might speculate that functional recovery have occurred since neuronal injury outside 
the CA1 region is very mild in our model (29). 
As outlined before, we have seen mild neuronal injury compared to similar models of cardiac 
arrest. For example, Brücken’s group used a 7 min cardiac arrest time, adding up the time to 
ROSC results in a combined no-flow/low-flow time of 645 sec (30). Boettiger’s group 
usually uses 6 minutes of CA, and resuscitations takes about 160 sec, adding up to 520 sec 
(16), which is less than our 650 sec in the 10 minutes cardiac arrest groups. The 
postresuscitation care is similar to what is done by Brücken (ventilation for 4-5 hours), but 
early weaning from ventilation is usually done in Boettiger’s experiments. Both groups use 
electrical currency to induce ventricular fibrillation, which might result in prolonged 
myocardial stunning and cardiac failure (31). This might explain the relatively low 
postresuscitation mortality in our experiments, which precluded survival analysis in series 1. 
and resulted in a probably underpowered “false negative” result in survival analysis in 
series2. In our model, cardiac arrest is induced with potassium and esmolol, a short-acting β-
receptor antagonist. Neuroprotective properties of beta-blocking substances have been 
discussed (32), but esmolol is relatively short-living and should not cross the blood-brain 
barrier. We think the neuropotective effect of esmolol is small, if ever, but we cannot exclude 
an effect. 
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This is the first in-vivo study performed so far on pifithrin-µ administration in animals that 
underwent cardiac arrest and resuscitation. The main strength of our study is that we 
employed a reproducible cardiac arrest model, with standardized post-cardiac arrest 
conditions. A limitation of our study is the wide variability of the results, particularly in 
neurobehavioral tests. The significant reduction of the cell layer breadth of the CA1 segment 
in the pifithrin-µ group (table suppl. 4, http://links.lww.com/SHK/A595) must be interpreted 
cautiously because the borders of the CA1 segment is difficult to delineate in the u-shaped 
hippocampus and cannot be standardized by simple manners. We therefore decided to abstain 
from this examination in the second series.  
The results in the CV staining did not reach statistical significance, which is unexpected, 
given the results of the Fluoro Jade B staining. We think this is due to two circumstances. 
First, determination of damage by cresyl violet staining, which is a non-specific stain, relies 
on purely morphological criteria (shrunken appearance and condensed nucleus) and is not 
firm, compared the easily identifiable degenerating neurons in the FJB staining. Second, 
since hippocampal damage after ischemic event is an evolving mechanism, assessment of 
neuronal damage with the CV staining based on morphological criteria is likely to detect cell 
death in a more advanced stage. In contrast, FluoroJade staining already labels damaged 
neurons with a rather intact morphology. Therefore results are likely to differ between both 
methods, depending on the time at which brains were harvested after the insult. Such 
differences between staining methods have been reported previously, although in different 
models (33, 34). The trend in the CV staining show in the same direction as the FJB staining, 
which supports our results. 
The current literature exhibits insufficient knowledge of dose, timing, duration, and diluents 
of pifithrin-µ. In our first series, we have administered 8 mg/kg of pifithrin-μ intraperitonally, 
which is based on the experiment of Nijboer et al. (10). Nijboer has used two different doses 
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of pifithrin-μ (2 and 8 mg/kg), the lower dose had no effect. To circumvent the insecurity of 
intraperitoneal drug administration, we have used an intravenous formulation in the second 
series. We have used a dose of 12 mg/kg of pifithrin-μ in ethanol (instead of DSMO) as a 
starting point, but did not see a dose effect. This has to be explored by further animal studies. 
Furthermore, the effect of pifithrin-μ on systemic inflammatory response is not yet known. In 
addition, since permanent damage or dysfunctional p53 invariably leads to cancer, and other 
untoward effects of temporary blockade of p53 might arise (e.g. adverse remodeling of 
myocardial infarct zone even though reduced myocyte apoptosis (26)) the long-term effects 
of temporary p53 inhibition needs be studied in the future. 
 
Conclusion 
After cardiac arrest and resuscitation, temporary inhibition of the neuronal apoptosis via the 
mitochondrial pathway with the small molecule pifithrin-µ reduces neuronal damage in the 
brain’s most vulnerable area, the hippocampus CA1 region, compared to control. The optimal 
dose, route of administration, and long term effects of temporarily blocking apoptosis need to 
be studied further. 
 
List of abbreviations 
CA-1: Cornu Ammonis 1 segment of the hippocampus 
CV: cresyl violet 
DMSO: dimethylsulfoxide 
FJB: Fluoro-Jade B 
IQR: interquartile range 
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PBS: phosphate buffered saline 
ROSC: return of spontaneous circulation 
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Figure Legends 
Figure 1: Flow chart of the number of animals assigned into the different groups of series 1. 6 
animals were assigned to a sham group before randomization for laboratory standardization 
purposes and quality control. These animals were not analyzed. The remaining 74 rats were 
randomized before resuscitation to treatment group and to observation period (1, 5 and > 10 
days).  
>10 days refers to the animals which were tested in the watermaze after wound healing, 
starting the watermaze trial between day 10 and 14. Animals which could not be resuscitated 
were replaced immediately replaced with an animal from the same group and duration 
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Figure 2: Left: Flow chart of the number of animals assigned into the different groups of 
series 2, Right: Survival analysis of the animals in series 2. 
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Figure 3: Representative pictures of the hippocampus where the green fluorescent neurons 
demonstrate degeneration. The right histological images (C and D)  shows a cardiac arrest 
animal, contra to the left (A and B), which depicts a sham animal, which did not underwent 
cardiac arrest and resuscitation. Overview of the whole hippocampal structures (B and D) are 
provided, while higher magnification (A and C) show degenerating neurons in the CA1 
segment.  
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Tables 
 
Table 1: Neuronal damage: histomorphometry of the hippocampus CA1 segment on 
day 5 with Fluoro-Jade 
 
variable series pifithrin control post-hoc t-test ANOVA 
Fluoro-Jade 
[numbers 
of stained 
cells/mm] 
Series 1. 
[8 min 
cardiac 
arrest] 
94 ± 46.9 128 ± 36.6 p: 0.084 p group: 0.014 
p exp.: 0.064 
p group x exp: 
0.622 Series 2. [10 min 
cardiac arrest 
78 ± 43.7 101 ± 31.0 p: 0.095 
 
Fluoro-Jade 
[normalized to 
control = 100%] 
Series 1. 
[8 min 
cardiac 
arrest] 
73 ± 36.6 100 ± 28.5 p: 0.084 p group: 0.019 
p exp.: 0.850 
p group x exp: 
0.850 
Series .2 
[10 min 
cardiac 
arrest] 
77 ± 43.3 100 ± 31.7 p: 0.095 
Fluoro Jade is a marker for degenerating neurons. The stained CA1 segment of the rat’s 
hippocampus were examined and results are given in absolute cell counts per mm CA1 (top), 
and as percentage in relation to the control group (=100%, bottom). (numbers are mean ± 
standard deviation) 
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Table 2: Neuronal damage: histomorphometry of the hippocampus CA1 segment on 
day 5 with Cresy Violett 
 
variable Serie pifithrin control post-hoc t-test ANOVA 
pyknotic cells in 
CA1 [%] 
Series 1. 
[8 min  
cardiac 
arrest] 
25 ± 16.7 39 ± 21.4 p: 0.111 p group: 0.118 
p exp.: 0.039 
p group x exp.: 
0.830 
Series 2. 
[10 min 
cardiac 
arrest] 
43 ± 28.8 53 ± 26.3 p: 0.321 
 
pyknotic cells 
[normalized to 
control = 100%] 
Series 1. 
[8 min 
cardiac 
arrest] 
65 ± 43.3 100 ± 55.5 p: 0.111 p group: 0.063 
p exp.: 0.552 
p group x time: 
0.552 
Series 2. 
[10 min 
cardiac 
arrest] 
81 ± 54.3 100 ± 49.5 p: 0.321 
Pyknotic appearing cells determine apoptosis. The stained CA1 segment of the rat’s 
hippocampus were examined and results are given in absolute cell counts per mm CA1 (top), 
and as percentage in relation to the control group (=100%, bottom) (numbers are mean ± 
standard deviation) 
 
 
 
